Digital Diagnostics LumineticsCore is an unclaimed profile.
If you work at Digital Diagnostics, sign up or log in to claim the profile today.
Product Overview
Security and Compliance Certifications: HIPAA
LumineticsCore by Digital Diagnostics is an AI diagnostic system that autonomously detects diabetic retinopathy, including macular edema, at the point-of-care using fundus images captured by a trained operator. It provides rapid results without needing specialist review, which facilitates immediate care decisions and referrals if disease is detected. The system is designed for healthcare providers, eye care professionals, payors, and patients, enhancing access to diagnostic evaluations for people with diabetes.
Customers Served
Categories
Company Info
HQ Location
Coralville, Iowa
Founded
2010
Headcount
51-200
Total Funding
$173.4M
Latest Round
Series B
Latest Round
08/23/2022
Company Socials
Demos
Customers
3
Verified customers
Specialty
0
1
2
3
Primary Care (3)
Showcased Customers
See all (3)
CARPL
CARPL
Company Info
Founded: 2018
Headcount: 11-50
Customers
Verified Customers: 5
Customers Served: Hospital / Health System, Ambulatory Practice
Product Overview
Security and Compliance Certifications: HIPAA, ISO 27001
CARPL provides a radiology AI platform that simplifies the integration, validation, and deployment of AI solutions within radiology departments. It offers access to over 110 AI applications from various vendors, enabling integration with existing PACS and RIS systems. The platform is designed to support scalable AI deployments, streamline workflows, and enhance diagnostic accuracy by providing a unified interface for managing AI solutions across different radiology tasks.
Other Categories
Cleerly
Cleerly
Company Info
Founded: 2017
Customers
Verified Customers: 2
Customers Served: Ambulatory Practice, Hospital / Health System
Product Overview
Security and Compliance Certifications: SOC 2 Type 2, HIPAA
Cleerly is an AI-based digital care platform for the diagnosis of heart disease. It utilizes coronary computed tomography angiography (CCTA) to provide analyses of atherosclerosis, plaque buildup and stenosis, through machine learning algorithms. The technology creates 3D models of coronary arteries for early heart disease detection and treatment plans. It includes the Cleerly Proxy and Cleerly ISCHEMIA for coronary artery disease.
Other Categories
Envisionit Deep AI
Envisionit Deep AI
Company Info
Founded: 2019
Headcount: 11-50
Customers
Customers Served: Hospital / Health System, Ambulatory Practice
Product Overview
Security and Compliance Certifications: FDA Approval
Envisionit Deep AI develops AI-driven radiology solutions, including RADIFY for automated image analysis and RATify for real-time AI model monitoring. Their tools are designed to assist radiologists with triaging and diagnostic support, particularly for critical conditions like pneumothorax and pleural effusion. The platform supports applications in teleradiology, training, and research, aiming to enhance diagnostic accuracy and accessibility.
Other Categories